BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37478668)

  • 1. Intermittent hypoxia inhibits anti-tumor immune response via regulating PD-L1 expression in lung cancer cells and tumor-associated macrophages.
    Cui Z; Ruan Z; Li M; Ren R; Ma Y; Zeng J; Sun J; Ye W; Xu W; Guo X; Xu D; Zhang L
    Int Immunopharmacol; 2023 Sep; 122():110652. PubMed ID: 37478668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages.
    Liu Y; Lu M; Chen J; Li S; Deng Y; Yang S; Ou Q; Li J; Gao P; Luo Z; Yuan P; Tan J; Gao X
    Sleep Breath; 2022 Jun; 26(2):893-906. PubMed ID: 34254261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent hypoxia-induced PD-L1 upregulation in patients with obstructive sleep apnoea.
    Cubillos-Zapata C; Balbás-García C; Avendaño-Ortiz J; Toledano V; Torres M; Almendros I; Casitas R; Zamarrón E; García-Sánchez A; Feliu J; Aguirre LA; Farre R; López-Collazo E; García-Rio F
    Respirology; 2019 Jul; 24(7):684-692. PubMed ID: 30656807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
    Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
    Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
    Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
    Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.
    Noman MZ; Desantis G; Janji B; Hasmim M; Karray S; Dessen P; Bronte V; Chouaib S
    J Exp Med; 2014 May; 211(5):781-90. PubMed ID: 24778419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor-associated macrophages (TAMs)-derived osteopontin (OPN) upregulates PD-L1 expression and predicts poor prognosis in non-small cell lung cancer (NSCLC).
    Li Y; Liu H; Zhao Y; Yue D; Chen C; Li C; Zhang Z; Wang C
    Thorac Cancer; 2021 Oct; 12(20):2698-2709. PubMed ID: 34423566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent hypoxia promotes melanoma lung metastasis via oxidative stress and inflammation responses in a mouse model of obstructive sleep apnea.
    Li L; Ren F; Qi C; Xu L; Fang Y; Liang M; Feng J; Chen B; Ning W; Cao J
    Respir Res; 2018 Feb; 19(1):28. PubMed ID: 29433520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent hypoxia enhances the tumor programmed death ligand 1 expression in a mouse model of sleep apnea.
    Huang MH; Zhang XB; Wang HL; Li LX; Zeng YM; Wang M; Zeng HQ
    Ann Transl Med; 2019 Mar; 7(5):97. PubMed ID: 31019947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
    Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
    J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effect of intermittent hypoxia and sleep fragmentation on PD-1/PD-L1 upregulation.
    Cubillos-Zapata C; Almendros I; Díaz-García E; Toledano V; Casitas R; Galera R; López-Collazo E; Farre R; Gozal D; García-Rio F
    Sleep; 2020 May; 43(5):. PubMed ID: 31782790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8
    Fang W; Zhou T; Shi H; Yao M; Zhang D; Qian H; Zeng Q; Wang Y; Jin F; Chai C; Chen T
    J Exp Clin Cancer Res; 2021 Jan; 40(1):4. PubMed ID: 33390170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 regulates PD-L1 expression via HIF-1α in non-small cell lung cancer cells.
    Zhao Y; Wang XX; Wu W; Long H; Huang J; Wang Z; Li T; Tang S; Zhu B; Chen D
    Biochem Biophys Res Commun; 2019 Sep; 517(2):201-209. PubMed ID: 31331645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of programmed death-ligand 1 and hypoxia-inducible factor-1α proteins in endometrial carcinoma.
    Tawadros AIF; Khalafalla MMM
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1063-S1069. PubMed ID: 30539847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
    Shima T; Shimoda M; Shigenobu T; Ohtsuka T; Nishimura T; Emoto K; Hayashi Y; Iwasaki T; Abe T; Asamura H; Kanai Y
    Cancer Sci; 2020 Feb; 111(2):727-738. PubMed ID: 31821665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of galectin-3 augments the antitumor efficacy of PD-L1 blockade in non-small-cell lung cancer.
    Zhang H; Liu P; Zhang Y; Han L; Hu Z; Cai Z; Cai J
    FEBS Open Bio; 2021 Mar; 11(3):911-920. PubMed ID: 33455075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea.
    Cubillos-Zapata C; Avendaño-Ortiz J; Hernandez-Jimenez E; Toledano V; Casas-Martin J; Varela-Serrano A; Torres M; Almendros I; Casitas R; Fernández-Navarro I; Garcia-Sanchez A; Aguirre LA; Farre R; López-Collazo E; García-Rio F
    Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma.
    Chang YL; Yang CY; Lin MW; Wu CT; Yang PC
    Eur J Cancer; 2016 Jun; 60():125-35. PubMed ID: 27107327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic Analysis of NSCLC Based on the Tumor-associated Macrophages, Tumor Neo-vessels and PD-L1 Expression in Tumor Microenvironment].
    Hang Q; Ying H; Cheng G; Yang S; Jin J; Chen Y; Chen Q; Jiang Y; Zhao Q; Fang M; Chen M; Lai X
    Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):837-844. PubMed ID: 33070512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.